Jeff Yass’s Alexza Pharmaceuticals Inc ALXA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-41,400
| Closed | -$20K | – | 9946 |
|
|
2016
Q1 | $20K | Buy |
+41,400
| New | +$18.1K | ﹤0.01% | 8811 |
|
|
2015
Q4 | – | Sell |
-13,100
| Closed | -$17K | – | 10436 |
|
|
2015
Q3 | $17K | Buy |
+13,100
| New | +$15.3K | ﹤0.01% | 9516 |
|
|
2015
Q2 | – | Sell |
-20,000
| Closed | -$41K | – | 10737 |
|
|
2015
Q1 | $41K | Sell |
20,000
-173,700
| -90% | -$357K | ﹤0.01% | 9187 |
|
|
2014
Q4 | $289K | Sell |
193,700
-1,100
| -0.6% | -$1.96K | ﹤0.01% | 8197 |
|
|
2014
Q3 | $454K | Sell |
194,800
-35,200
| -15% | -$134K | ﹤0.01% | 7390 |
|
|
2014
Q2 | $1.05M | Buy |
230,000
+100
| +0% | +$432 | ﹤0.01% | 5959 |
|
|
2014
Q1 | $1.02M | Sell |
229,900
-10,500
| -4% | -$53.8K | ﹤0.01% | 5496 |
|
|
2013
Q4 | $1.14M | Sell |
240,400
-66,800
| -22% | -$328K | ﹤0.01% | 5287 |
|
|
2013
Q3 | $1.57M | Sell |
307,200
-83,300
| -21% | -$392K | ﹤0.01% | 4513 |
|
|
2013
Q2 | $1.7M | Buy |
+390,500
| New | +$1.77M | ﹤0.01% | 4163 |
|
Jeff Yass's ALXA Position: Q2 2016 in Review
Jeff Yass sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 26,110 shares — an estimated $13K sold.
Jeff Yass first reported a position in ALXA in Q4 2013 and held it in 6 quarters. The position peaked at $115K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.
- Jeff Yass reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
- Jeff Yass sold 26,110 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $13K.
- Jeff Yass first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
- Jeff Yass's Alexza Pharmaceuticals Inc position peaked at $115K in Q4 2013.
- 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.
Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.